theravance inc (THRX:NASDAQ GS)
George M. Whitesides Ph.D.
Co-Founder, Director, Member of Compensation Committee and Member of Science & Technology Advisory Committee, Theravance Inc.
|Age||Total Calculated Compensation||This person is connected to 111 board members in 12 different organizations across 13 different industries.|
See Board Relationships
Dr. George M. Whitesides, Ph.D. is a co-founder of companies with a combined market capitalization of over $20 billion. In the early 80s, Dr. Whitesides co-founded biotechnology company Genzyme. In 1993 he co-founded GelTex, which was acquired by Genzyme for $1.2 billion; and in 1996, he co-founded Theravance, which went public in 2004. Professor Whitesides’ more recent ventures include Surface Logix and WMR Biomedical. Dr. Whitesides has held advisory positions on the ...
901 Gateway BoulevardPhone: 650-808-6000
South San Francisco, California 94080
Board Members Memberships*
Co-Founder, Scientific Advisor and Director
Former Member of Scientific Advisory Board
Chairman and Head of Science Advisory Board
Co-Founder and Director
Co-Founder and Member of The Board of Directors
Co-Founder, Director, Member of Compensation Committee and Member of Science & Technology Advisory Committee
Director, Member of Nominating Committee and Member of Sustainable Development Committee
California Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Michael W. Bonney B.A.||Chief Executive Officer and Director|
Cubist Pharmaceuticals Inc.
|Howard W. Robin||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|Mark R. Baker J.D.||Chief Executive Officer, Director, Member of Science & Technology Committee and Member of Strategy & External Technology Subcommittee|
Progenics Pharmaceuticals, Inc.
|Ryuji Ueno M.D., Ph.D., Ph.D.||Co-Founder, Chairman, Chief Executive Officer, Chief Scientific Officer and Member of Science & Technology Committee|
Sucampo Pharmaceuticals, Inc.
|$589.0K||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- South San Francisco, CA | TheravancePosted: Nov 29
- South San Francisco, CA | TheravancePosted: Nov 22
- South San Francisco, CA | TheravancePosted: Nov 13
- South San Francisco, CA | TheravancePosted: Nov 06